LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Loong, H. H. F.; Goto, K.; Elamin, Y. Y.; Solomon, B.; Santini, F. C.; Soldatenkova, V.; Sashegyi, A.; Bence Lin, A.; Lin, B. K.; Wolf, J.; Oxnard, G. R.; Zhou, C.; Drilon, A.; Park, K.
Abstract Title: LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S893
Language: English
ACCESSION: WOS:000573469102006
DOI: 10.1016/j.annonc.2020.08.1727
PROVIDER: wos
Notes: Meeting Abstract: 1413TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon